C WorldWide Group Holding A S Acquires 4,945 Shares of Thermo Fisher Scientific Inc. (TMO)

C WorldWide Group Holding A S raised its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.2% in the 3rd quarter, Holdings Channel reports. The firm owned 2,241,502 shares of the medical research company’s stock after buying an additional 4,945 shares during the period. Thermo Fisher Scientific makes up approximately 7.0% of C WorldWide Group Holding A S’s holdings, making the stock its 5th largest holding. C WorldWide Group Holding A S’s holdings in Thermo Fisher Scientific were worth $547,106,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Pitcairn Co. increased its position in shares of Thermo Fisher Scientific by 1.3% in the second quarter. Pitcairn Co. now owns 16,871 shares of the medical research company’s stock worth $3,495,000 after purchasing an additional 215 shares during the period. Nvwm LLC increased its position in shares of Thermo Fisher Scientific by 6.1% in the second quarter. Nvwm LLC now owns 4,231 shares of the medical research company’s stock worth $877,000 after purchasing an additional 242 shares during the period. Tiedemann Advisors LLC increased its position in shares of Thermo Fisher Scientific by 19.4% in the second quarter. Tiedemann Advisors LLC now owns 1,518 shares of the medical research company’s stock worth $315,000 after purchasing an additional 247 shares during the period. Chesapeake Wealth Management increased its position in shares of Thermo Fisher Scientific by 6.0% in the second quarter. Chesapeake Wealth Management now owns 4,393 shares of the medical research company’s stock worth $910,000 after purchasing an additional 249 shares during the period. Finally, Middleton & Co Inc MA increased its position in shares of Thermo Fisher Scientific by 2.3% in the third quarter. Middleton & Co Inc MA now owns 11,123 shares of the medical research company’s stock worth $2,715,000 after purchasing an additional 250 shares during the period. 85.22% of the stock is owned by institutional investors and hedge funds.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 125,520 shares of Thermo Fisher Scientific stock in a transaction dated Monday, October 1st. The stock was sold at an average price of $247.50, for a total value of $31,066,200.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific stock opened at $245.57 on Friday. Thermo Fisher Scientific Inc. has a 12-month low of $181.51 and a 12-month high of $249.95. The company has a current ratio of 1.84, a quick ratio of 1.27 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $95.91 billion, a price-to-earnings ratio of 25.88, a price-to-earnings-growth ratio of 1.73 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, October 24th. The medical research company reported $2.62 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.55 by $0.07. Thermo Fisher Scientific had a return on equity of 16.49% and a net margin of 10.75%. The firm had revenue of $5.92 billion for the quarter, compared to analysts’ expectations of $5.70 billion. During the same quarter in the previous year, the business posted $2.31 earnings per share. The business’s revenue for the quarter was up 15.7% on a year-over-year basis. As a group, equities analysts anticipate that Thermo Fisher Scientific Inc. will post 11.04 earnings per share for the current fiscal year.

Thermo Fisher Scientific declared that its board has initiated a share buyback plan on Friday, September 7th that allows the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization allows the medical research company to reacquire up to 2.1% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company’s leadership believes its stock is undervalued.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Shareholders of record on Monday, December 17th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio is presently 7.17%.

A number of brokerages recently commented on TMO. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $261.00 price target on the stock in a research report on Monday, August 6th. Leerink Swann raised their price target on Thermo Fisher Scientific from $239.00 to $255.00 and gave the stock an “outperform” rating in a research report on Thursday, July 26th. ValuEngine upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research report on Tuesday, July 24th. UBS Group began coverage on Thermo Fisher Scientific in a research report on Tuesday, October 9th. They issued a “buy” rating and a $295.00 price target on the stock. Finally, JPMorgan Chase & Co. restated an “overweight” rating and issued a $300.00 price target on shares of Thermo Fisher Scientific in a research report on Thursday, July 26th. Two equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $261.45.

COPYRIGHT VIOLATION WARNING: This news story was reported by WKRB News and is the property of of WKRB News. If you are reading this news story on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this news story can be accessed at https://www.wkrb13.com/2018/11/09/c-worldwide-group-holding-a-s-acquires-4945-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Read More: Retained Earnings

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply